medigraphic.com
ISSN 1527-3172 (Digital)

2013, Número 1

<< Anterior Siguiente >>

MEDICC Review 2013; 15 (1)


Usefulness of nuclear cardiology techniques for silent ischemia detection in diabetics

Peix A

Idioma: Ingles.
Referencias bibliográficas: 27
Paginas: 33-36
Archivo PDF: 173.96 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047–53.

  2. Backer G, Ambrosioni E, Boch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (consulted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2003;10 Suppl:S1–78.

  3. Estadísticas Sanitarias Mundiales [Internet]. Geneva: World Health Organization; 2012 [cited 2012 Aug 5]. 178 p. Available from: www.who.int/ gho/publictions/world_health_statistics/2012/es/ index.html. Spanish.

  4. Wackers FG, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004 Aug;27(8):1954–61.

  5. Papaioannu G, Kasapis C, Seip RL, Grey NJ, Katten D, Wackers FJ, et al. Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imaging. J Nucl Cardiol. 2006 May–Jun;13(3):362–8.

  6. American Diabetes Association. Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care. 2003 Mar;26 Suppl 1:S33–50.

  7. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002 Oct 1;106(14):1883–92.

  8. Fateh-Moghadam S, Reuter T, Htun P, Plöckinger U, Dietz R, Bocksch W. Stress echocardiography for risk stratifi cation of asymptomatic patients with type 2 diabetes mellitus. Int J Cardiol. 2009 Jan 9;131(2):288–90.

  9. Jacqueminet S, Barthélémy O, Le Feuvre C. Screening of silent myocardial ischemia in type 2 diabetic patients: a randomized trial comparing isotopic and echocardiographic stress tests. Diabetes Care. 2010 Jun;33:e79.

  10. Beller GA, Heede RC. SPECT imaging for detecting coronary artery disease and determining prognosis by noninvasive assessment of myocardial perfusion and myocardial viability. J Cardiovasc Transl Res. 2011 Aug;4(4):416–24.

  11. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, et al. Risk stratifi cation in uncomplicated type 2 diabetes: Prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006 Mar;27(6):713–21.

  12. Raggi P, Shaw LJ, Berman DS, Callister TQ. Prognostic value of coronary calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004 May 5;43(9):1663–9.

  13. Celermajer D, Sorensen K, Gooch V, Spiegelhalter D, Miller O, Sullivan I. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992 Nov;340(8828):1111–5.

  14. Marcus ML, Chilian WM, Kanatsuka H, Dellsperger KC, Eastham CL, Lamping KG. Understanding the coronary circulation through studies at the microvascular level. Circulation. 1990 Jul;82(1):1–7.

  15. Peix A, Cabrera LO, Heres F, Rodríguez L, Valdés A, Valiente J, et al. Interrelationship between myocardial perfusion imaging, coronary calcium score, and endothelial function in asymptomatic diabetes and controls. J Nucl Cardiol. 2011 May;18(3):398–406.

  16. Rajagopalan N, Miller TD, Hodge DO, Frye RL, Gibbons RJ. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. J Am Coll Cardiol. 2005 Jan 4;45(1):43–9.

  17. Zellweger MJ, Hachammovitch R, Kang X, Hayes SW, Friedman JD, Germano G, et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004 Apr;25(7):543–50.

  18. Peña Y, Coca M, Batista J, Fernández-Britto J, Quesada R, Peña A. Utilidad de la tomografía computarizada de emisión de fotón único sincronizada con el electrocardiograma para la detección de isquemia miocárdica silente en diabéticos tipo 2. Rev Méd Chile. 2009;137:1023–30. Spanish.

  19. Peña Y, Fernández-Britto JE, Bacallao J, de León ML. Lipid levels as predictors of silent myocardial ischemia in a type 2 diabetic population in Havana. MEDICC Rev. 2012 Jan;14(1):18–24.

  20. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets- Schneider P, Stokkel MP, van der Wall EE, et al. Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imag. 2009 Apr;36(4):567–75.

  21. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/ AHA 2007 Clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain. J Am Coll Cardiol. 2007 Jan 23;49(3):378–402.

  22. Iwasaki K, Matsumoto T, Aono H, Furukawa H, Samukawa M. Prevalence of subclinical atherosclerosis in asymptomatic diabetic patients by 64-slice computed tomography. Coron Artery Dis. 2008 May;19(3):195–201.

  23. Zeina A, Odeh M, Rosenschein U, Zaid G, Barmeir E. Coronary artery disease among asymptomatic diabetic and nondiabetic patients undergoing coronary computed tomography angiography. Coron Artery Dis. 2008 Feb;19(1):37–41.

  24. Scholte A, Schuijf J, Kharagjitsingh A, Jukema J, Pundziute G, van der Wall E, et al. Prevalence of coronary artery disease and plaque morphology assessed by multislice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes. Heart. 2008;94(3):290–5.

  25. Nagamachi S, Fujita S, Nishii R, Futami S, Tamura S, Mizuta M, et al. Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus. J Nucl Cardiol. 2006 Jan– Feb;13(1):34–42.

  26. Wackers FJ, Chyun DA, Young LH, Heller GV, Iskandrian AE, Davey JA, et al. Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. Diabetes Care. 2007 Nov;30(11):2892–8.

  27. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes. The DIAD Study: a randomized controlled trial. JAMA. 2009 Apr 15;301(15):1547–55.




2020     |     www.medigraphic.com